AL-4114
AL-4114 is an aldose reductase inhibitor which can be utilized in research related to the prevention of diabetic cataractogenesis[1].
Product Specifications
CAS Number
139911-05-0
UNSPSC
12352005
Target
Aldose Reductase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/al-4114.html
Smiles
O=C1NC(C2(C3=C(C4=C2C=C(F)C=C4OC)C(OC)=CC(F)=C3)N1)=O
Molecular Formula
C17H12F2N2O4
Molecular Weight
346.28
References & Citations
[1]Sastry SG, et al. Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits. Drug Metab Dispos. 1995 Oct;23 (10) :1094-8.|[2]Sastry SG, et al. Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits. Drug Metab Dispos. 1995 Oct;23 (10) :1094-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941983-100 1x 100 µL
Carcinoembryonic Antigen (CEA) / CD66 (C66/1983R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
